Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 176.63B | 176.77B | 172.66B | 141.32B | 110.91B | 99.79B |
Gross Profit | 75.45B | 75.74B | 75.12B | 59.38B | 46.53B | 41.18B |
EBITDA | 45.49B | 47.50B | 44.85B | 36.82B | 29.27B | 24.41B |
Net Income | 29.21B | 29.78B | 28.04B | 23.48B | 18.13B | 14.78B |
Balance Sheet | ||||||
Total Assets | 199.05B | 208.54B | 182.68B | 172.30B | 136.68B | 113.37B |
Cash, Cash Equivalents and Short-Term Investments | 21.97B | 19.33B | 11.22B | 11.85B | 19.58B | 11.65B |
Total Debt | 0.00 | 0.00 | 32.71B | 36.30B | 24.85B | 24.63B |
Total Liabilities | 88.36B | 94.78B | 91.18B | 92.28B | 69.05B | 59.83B |
Stockholders Equity | 110.63B | 113.70B | 91.45B | 79.98B | 67.63B | 53.22B |
Cash Flow | ||||||
Free Cash Flow | 30.88B | 30.86B | 22.63B | 16.35B | 19.79B | 19.41B |
Operating Cash Flow | 38.24B | 36.89B | 28.08B | 21.38B | 23.15B | 22.20B |
Investing Cash Flow | -13.78B | -13.32B | -9.39B | -15.50B | -6.12B | -16.29B |
Financing Cash Flow | -17.55B | -15.86B | -18.28B | -14.65B | -10.32B | -8.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $136.23B | 34.56 | 20.84% | 1.19% | 7.00% | 16.84% | |
77 Outperform | $86.06B | 25.92 | 27.16% | 1.04% | -0.23% | 22.41% | |
77 Outperform | $71.99B | 21.63 | 107.62% | 2.43% | -1.85% | 12.04% | |
77 Outperform | $60.95B | 40.89 | 8.09% | 0.58% | 13.34% | 1.98% | |
76 Outperform | $74.66B | 30.89 | 9.82% | 1.59% | 6.49% | 24.14% | |
74 Outperform | $76.16B | 28.89 | 26.41% | 1.97% | 0.18% | 1.44% | |
71 Outperform | ¥255.65B | 12.96 | 8.49% | 3.12% | 6.31% | 12.92% |